ESMO Examination for Medical Oncologists
ESMO examination 2014
The main session of the 2014 ESMO examination will take place on 27 September 2014, during the ESMO 2014 congress in Madrid, Spain. Parallel sessions will be held in: Lucerne, Switzerland; Berlin, Germany; Cairo, Egypt and Chennai, India. Online registration is now closed.
ESMO members: forgotten to register for the exam?
There are still a few seats left at the main examination session in Madrid. Registration will take place on site and further information will be communicated on this page mid-September. Places are reserved for ESMO members only.
Registration fees and deadlines
The ESMO examination is open to ESMO Full and Junior members, members of the AIO and DGHO (Germany) and members of the FMH (Switzerland)
|Deadline||ESMO member fee||AIO, DGHO, FMH member fee|
|Early registration: 15 March 2014||€60||€300|
|Late registration: 21 July 2014||€200||€300|
About the exam
The ESMO examination is a valuable assessment tool for practising medical oncologists and an excellent opportunity for medical oncologists in training to assess their knowledge. The ESMO Examination is the written part of the Board Certification in Medical Oncology in Switzerland and Slovenia. In all other countries the ESMO Examination certifies an excellent knowledge in the field of Medical Oncology according to the criteria of the European Society for Medical Oncology. The ESMO Examination has no legal standing since only national authorities can grant physicians the right to practice.
In 2013, 268 candidates sat the ESMO examination. The main session was at the European Cancer Congress 2013, Amsterdam, The Netherlands, with parallel sessions in Cairo, Egypt; Berlin, Germany; Ahmedabad-Gujarat, India and Lucern, Switzerland.
Successful candidates will be certified for five years. After five years recertification can be attained either by re-taking the ESMO Examination (on passing, recertification is valid for a further five years) or for ESMO members participation in the ESMO Medical Oncologist’s Recertification Approval (MORA) which is a proof of continuing medical education – allowing ESMO members to remain certified in medical oncology. If approved, the recertification is also valid for five years.
The ESMO Examination is accredited with 50 category 1 ESMO-MORA CME points.
Questions cover all fields of medical oncology, including: basic elements of tumour path histology, epidemiology and biology. Besides all cancer types, the ESMO Examination includes practice-oriented issues on diagnosis, staging, management, evaluation and prognosis of cancer patients.
- Written examination of 150 minutes
- Pass score: 60% of correct answers
- 100 multiple choice questions are divided as follows:
- 60 type A questions
- 20 type B questions
- 20 type K questions
Preparing for the examination
To prepare for the ESMO examination, we recommend that applicants follow scientific updates published in the major oncology journals, including Annals of Oncology, and other educational material produced by ESMO.
The OncologyPRO Tumour Knowledge Portal groups ESMO resources according to the disease or the topic area and will help you find the educational material more easily.
ESMO Examination analysis is powered by the University of Bern, Switzerland. Representatives from the Institute for Medical Education of the University of Bern have acknowledged the authority of the ESMO Examination and its value as a high-quality assessment tool.
No information about the ESMO Examination's results will be communicated to third parties unless authorised by the candidate and only if requested.